Jazz Pharmaceuticals plc Stock
Jazz Pharmaceuticals plc Stock
A loss of -1.150% shows a downward development for Jazz Pharmaceuticals plc.
The stock is an absolute favorite of our community with 24 Buy predictions and no Sell predictions.
As a result the target price of 184 € shows a very positive potential of 89.61% compared to the current price of 97.04 € for Jazz Pharmaceuticals plc.
Pros and Cons of Jazz Pharmaceuticals plc in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
C******** o* t** e**********
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Jazz Pharmaceuticals plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc | -1.150% | -0.736% | -6.513% | -19.100% | -13.008% | -33.397% | -17.763% |
| Opko Health Inc. | 3.200% | 3.859% | 11.712% | 0.093% | -8.968% | -59.040% | -19.278% |
| Catalent Inc. | 0.650% | -1.861% | -5.237% | 42.267% | 20.340% | -42.349% | 22.269% |
| Repligen Corp. | -1.020% | -5.628% | -11.262% | -12.532% | -17.959% | -9.747% | - |
Comments
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $200.00 price target on the stock.
Show more
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target lowered by analysts at Barclays PLC from $230.00 to $200.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for JAZZ provided by MarketBeat